Zimberelimab plus chemotherapy as the first-line treatment of malignant peritoneal mesothelioma: A case report and review of literature

BACKGROUND: Malignant peritoneal mesothelioma (MPeM) is a rare cancer with a poor prognosis at advanced stage, and the standard first-line treatment for inoperable patients is chemotherapy. Although combining programmed cell death 1 (PD-1) inhibitors with chemotherapy is generally considered safe an...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Xiao-Dong, You, Zhen-Yu, He, Lian-Xiang, Deng, Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445078/
https://www.ncbi.nlm.nih.gov/pubmed/37621601
http://dx.doi.org/10.12998/wjcc.v11.i22.5296

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445078/
https://www.ncbi.nlm.nih.gov/pubmed/37621601
http://dx.doi.org/10.12998/wjcc.v11.i22.5296

Ejemplares similares